NCT01148615 - A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

December 31, 2011

Conditions

Neoplasm Malignant

Interventions

DRUG

Aflibercept (AVE0005)

"Pharmaceutical form: solution for infusion~Route of administration: intravenous"

DRUG

Docetaxel (XRP6976)

"Pharmaceutical form: solution for infusion~Route of administration: intravenous"

Trial Locations (1)

Sanofi-Aventis Investigational Site Number 156001, Guangzhou